📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Development of in House ELISAs to Detect Antibodies to SARS-CoV-2 in Infected and Vaccinated Humans by Using Recombinant S, S1 and RBD Proteins. (2022)

First Author: Yilmaz A

Attributed to: High Containment funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/diagnostics12123085

PubMed Identifier: 36553092

Publication URI: http://europepmc.org/abstract/MED/36553092

Type: Journal Article/Review

Volume: 12

Parent Publication: Diagnostics (Basel, Switzerland)

Issue: 12

ISSN: 2075-4418